CTLA4 and neoplasm: The amplitude ratio of free NADH to protein‐bound NAD(P)H was significantly higher for immunotherapy responders (anti‐CTLA‐4‐therapy, multiple treatments) compared to non‐responders and an untreated tumour control group [131].